메뉴 건너뛰기




Volumn 22, Issue 21, 2012, Pages 6688-6693

The discovery of CCR3/H 1 dual antagonists with reduced hERG risk

Author keywords

Antagonist; Chemokine; hERG

Indexed keywords

ANTIHISTAMINIC AGENT; AZ 10565259; BISPIPERIDINE; CHEMOKINE RECEPTOR CCR ANTAGONIST; CHEMOKINE RECEPTOR CCR3 ANTAGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; PIPERIDINE DERIVATIVE; POTASSIUM CHANNEL HERG; UNCLASSIFIED DRUG; CCR3 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR3; KCNH1 PROTEIN, HUMAN; PIPERIDINE;

EID: 84867582657     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.08.124     Document Type: Article
Times cited : (8)

References (36)
  • 5
    • 77956493552 scopus 로고    scopus 로고
    • Chemokine CCR3 antagonists
    • by Hansel T. T., Barnes P. J. (Eds.), series edited Bolliger C. T. (Ed.), Prog. R. Res., 2010
    • Bahl A, Springthorpe B and Riley R (2010). Chemokine CCR3 antagonists. In: New Drugs and Targets for Asthma and COPD. by Hansel T. T., Barnes P. J. (Eds.), series edited Bolliger C. T. (Ed.), Prog. R. Res., 2010,39, 153.
    • (2010) New Drugs and Targets for Asthma and COPD , vol.39 , pp. 153
    • Bahl, A.1    Springthorpe, B.2    Riley, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.